the challenges of treating bpdcn and the role of diagnostic markers
Published 2 years ago • 304 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
0:56
challenges associated with treating bpdcn: the rarity of the disease
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
1:41
improvements in the awareness and diagnosis of bpdcn
-
0:57
bpdcn: unmet needs and challenges
-
2:37
recent advances in the treatment of bpdcn & the long-term benefits of tagraxofusp
-
2:07
creative testing solutions
-
6:45
clonal hematopoiesis of indeterminate potential as a novel risk factor for stroke
-
10:41
blastic plasmacytoid dendritic cell neoplasm ( learn in 10 minutes)
-
1:10
current standard of care in bpdcn
-
2:09
major breakthroughs in bpdcn treatment
-
6:53
challenges of hypoparathyroidism
-
4:41
novel treatment approaches in bpdcn: the promise of cd123-targeting allogeneic car-t cells
-
3:07
frontline treatment in bpdcn & the best route to allogeneic transplantation
-
2:36
tagraxofusp for bpdcn gives encouraging results
-
2:03
challenges with mds classification: morphological characterization and molecular testing
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
1:35
challenges with diagnosing mds and future outlooks
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
1:44
long-term results from a trial of tag in patients with bpdcn
-
4:19
outcomes of patients with bpdcn after allohsct
-
1:28
evolution of clonal hematopoiesis to bpdcn
-
2:22
the challenges with monitoring patients with lymphoma for cardiotoxicity